Outcome of sustained virological responders with histologically advanced chronic hepatitis C-Reference-Cited by-同舟云学术

Outcome of sustained virological responders with histologically advanced chronic hepatitis C

Published:2010-05-14 Issue:3 Volume:52 Page:833-844
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Morgan Timothy R.,Ghany Marc G.,Kim Hae-Young,Snow Kristin K.,Shiffman Mitchell L.,De Santo Jennifer L.,Lee William M.,Di Bisceglie Adrian M.,Bonkovsky Herbert L.,Dienstag Jules L.,Morishima Chihiro,Lindsay Karen L.,Lok Anna S. F.,

Publisher

Wiley

Subject

Hepatology

Reference16 articles.

1. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data;Cammà;HEPATOLOGY,2004

2. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients;George;HEPATOLOGY,2009

3. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C;Poynard;Gastroenterology,2002

4. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study;Bruno;HEPATOLOGY,2007

5. Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study;Imazeki;HEPATOLOGY,2003

Cited by 419 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating microRNAs as potential biomarkers of physical activity in geriatric patients with HCV;BMC Molecular and Cell Biology;2024-07-19

2. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine;Frontiers in Pharmacology;2024-07-16

3. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents;Frontiers in Virology;2023-10-24

4. Liver cirrhosis: physiology, pathology, market analysis, treatments;Journal of Applied Biotechnology & Bioengineering;2023-10-17

5. Unmet Needs in the Post–Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication;The Journal of Infectious Diseases;2023-09-13